P

Inventor

WANG SHUNHAI

US59 patents
⚠️ This page may combine multiple inventors who share the name “WANG SHUNHAI”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

REGENERON PHARMA

48 patents
US11505593B2Nov 22, 2022

Anti-VEGF protein compositions and methods for producing the same

REGENERON PHARMA13 citations98
US11459374B2Oct 4, 2022

Anti-VEGF protein compositions and methods for producing the same

REGENERON PHARMA13 citations97
US11174283B2Nov 16, 2021

Anti-VEGF protein compositions and methods for producing the same

REGENERON PHARMA13 citations97
US11053280B2Jul 6, 2021

Anti-VEGF protein compositions and methods for producing the same

REGENERON PHARMA19 citations97
US11542317B1Jan 3, 2023

Anti-VEGF protein compositions and methods for producing the same

REGENERON PHARMA11 citations94
US11485770B2Nov 1, 2022

Anti-VEGF protein compositions and methods for producing the same

REGENERON PHARMA6 citations94
US11459373B2Oct 4, 2022

Anti-VEGF protein compositions and methods for producing the same

REGENERON PHARMA8 citations94
US11306135B2Apr 19, 2022

Anti-VEGF protein compositions and methods for producing the same

REGENERON PHARMA7 citations94
US11299532B2Apr 12, 2022

Anti-VEGF protein compositions and methods for producing the same

REGENERON PHARMA8 citations94
US11186625B2Nov 30, 2021

Anti-VEGF protein compositions and methods for producing the same

REGENERON PHARMA10 citations94
US11958894B2Apr 16, 2024

Anti-VEGF protein compositions and methods for producing the same

REGENERON PHARMA5 citations93
US11753459B2Sep 12, 2023

Anti-VEGF protein compositions and methods for producing the same

REGENERON PHARMA5 citations93
US11548932B2Jan 10, 2023

Anti-VEGF protein compositions and methods for producing the same

REGENERON PHARMA8 citations93
US11535663B2Dec 27, 2022

Methods for producing aflibercept in chemically defined media having reduced aflibercept variants

REGENERON PHARMA6 citations93
US11472861B2Oct 18, 2022

Methods for producing aflibercept in chemically defined media having reduced aflibercept variants

REGENERON PHARMA5 citations91
US11104715B2Aug 31, 2021

Methods for producing aflibercept in chemically defined media having reduced aflibercept variants

REGENERON PHARMA5 citations91
US12012445B2Jun 18, 2024

Anti-VEGF protein compositions and methods for producing the same

REGENERON PHARMA4 citations85
US12054532B2Aug 6, 2024

Anti-VEGF protein compositions and methods for producing the same

REGENERON PHARMA2 citations84
US12049489B2Jul 30, 2024

Anti-VEGF protein compositions and methods for producing the same

REGENERON PHARMA2 citations84
US11407813B2Aug 9, 2022

Anti-VEGF protein compositions and methods for producing the same

REGENERON PHARMA3 citations84
US11180540B2Nov 23, 2021

Anti-VEGF protein compositions and methods for producing the same

REGENERON PHARMA2 citations84
US12012444B2Jun 18, 2024

Anti-VEGF protein compositions and methods for producing the same

REGENERON PHARMA2 citations83
US11505594B2Nov 22, 2022

Anti-VEGF protein compositions and methods for producing the same

REGENERON PHARMA1 citations83
US12202883B2Jan 21, 2025

Anti-VEGF protein compositions and methods for producing the same

REGENERON PHARMA0 citations73
US12054533B2Aug 6, 2024

Anti-VEGF protein compositions and methods for producing the same

REGENERON PHARMA0 citations73
US11835528B2Dec 5, 2023

System and method of analysis of a protein using liquid chromatography-mass spectrometry

REGENERON PHARMA1 citations73
US11579150B2Feb 14, 2023

Methods for characterizing disulfide bonds

REGENERON PHARMA1 citations73
US11345929B2May 31, 2022

Methods for analysis of viral capsid protein composition

REGENERON PHARMA3 citations73
US11249089B2Feb 15, 2022

System and method of analysis of a protein using liquid chromatography-mass spectrometry

REGENERON PHARMA1 citations73
US10908166B2Feb 2, 2021

Dual-column LC-MS system and methods of use thereof

REGENERON PHARMA2 citations73
US12338274B2Jun 24, 2025

Anti-VEGF protein compositions and methods for producing the same

REGENERON PHARMA0 citations72
US12319728B2Jun 3, 2025

Anti-VEGF protein compositions and methods for producing the same

REGENERON PHARMA0 citations72
US12000811B2Jun 4, 2024

Method and system of identifying and quantifying antibody fragmentation

REGENERON PHARMA1 citations72
US11899023B2Feb 13, 2024

Quantitation and identification of dimers in co-formulations

REGENERON PHARMA2 citations72
US11536725B2Dec 27, 2022

Quantitation and identification of dimers in co-formulations

REGENERON PHARMA4 citations72
US11525823B2Dec 13, 2022

System and method for characterizing protein dimerization

REGENERON PHARMA1 citations72
US11525833B2Dec 13, 2022

Hydrophobic interaction chromatography-coupled native mass spectrometry for antibody analysis

REGENERON PHARMA1 citations72
US11385239B2Jul 12, 2022

Method and system of identifying and quantifying a protein

REGENERON PHARMA2 citations72
US10718754B2Jul 21, 2020

System and method for characterizing protein dimerization

REGENERON PHARMA2 citations72
US12535490B2Jan 27, 2026

Affinity chromatography-coupled native mass spectrometry for antibody analysis

REGENERON PHARMA0 citations63
US12480139B2Nov 25, 2025

Methods for analysis of viral capsid protein composition

REGENERON PHARMA0 citations63
US12247983B2Mar 11, 2025

Protein A chromatography-electrospray ionization mass spectrometer

REGENERON PHARMA0 citations63
US12174199B2Dec 24, 2024

System and method of analysis of a protein using liquid chromatography-mass spectrometry

REGENERON PHARMA0 citations63
US12000839B2Jun 4, 2024

Methods for characterizing disulfide bonds

REGENERON PHARMA0 citations63
US11981913B2May 14, 2024

Methods for analysis of viral capsid protein composition

REGENERON PHARMA0 citations63
US11740246B2Aug 29, 2023

Dual-column LC-MS system and methods of use thereof

REGENERON PHARMA0 citations63
US11435359B2Sep 6, 2022

Dual-column LC-MS system and methods of use thereof

REGENERON PHARMA0 citations63
US11366123B2Jun 21, 2022

Glucuronylation as a new acidic post-translational modification on therapeutic monoclonal antibodies

REGENERON PHARMA0 citations63

REGENERAN PHARMACEUTICALS INC

2 patents

Showing the top 50 of 59 patents by PatentIndex Score.